Voxel SA
WSE:VOX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/IC
Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.
Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.
Valuation Scenarios
If EV/IC returns to its 3-Year Average (2.1), the stock would be worth zł120.52 (21% upside from current price).
| Scenario | EV/IC Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 1.8 | zł99.9 |
0%
|
| 3-Year Average | 2.1 | zł120.52 |
+21%
|
| 5-Year Average | 1.5 | zł87.89 |
-12%
|
| Industry Average | 1.9 | zł106.25 |
+6%
|
| Country Average | 0.9 | zł50 |
-50%
|
Forward EV/IC
Today’s price vs future invested capital
Peer Comparison
| Market Cap | EV/IC | P/E | ||||
|---|---|---|---|---|---|---|
| PL |
V
|
Voxel SA
WSE:VOX
|
1B PLN | 1.8 | 10.6 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
104.3B USD | 0.8 | 59 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
72.9B EUR | 0.8 | 14.1 | |
| US |
|
Cigna Corp
NYSE:CI
|
74.5B USD | 0 | 12.5 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
23.2B EUR | 0.8 | 18.4 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.4B EUR | 1 | 22.8 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.4B USD | 1.8 | 21 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21B USD | 1.5 | 24 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.8B EUR | 0.6 | 11 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.4B USD | 15.8 | -27.5 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.4B USD | 1.2 | 13.9 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0.6 |
| Median | 0.9 |
| 70th Percentile | 1.9 |
| Max | 116.3 |
Other Multiples
Voxel SA
Glance View
Voxel SA engages in the provision of medical services. The company is headquartered in Krakow, Woj. Malopolskie and currently employs 546 full-time employees. The company went IPO on 2011-10-11. The company provides services in the fields of diagnostic imaging, teleradiology and outsourcing, as well as information technology (IT) systems for hospitals and diagnostic centers. As of December 31, 2011, the Company operated two subsidiaries, 95.24%-owned Alteris SA and wholly owned CDO Sp. z o.o. On November 7, 2012, the Company sold its entire stake in Centrum Diagnostyki i Terapii Onkologicznej Sp. z o.o.
